nodes	percent_of_prediction	percent_of_DWPC	metapath
Vapreotide—SSTR2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0307	0.0307	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0242	0.0242	CbGpPWpGaD
Vapreotide—SSTR5—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.0226	0.0226	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0219	0.0219	CbGpPWpGaD
Vapreotide—SSTR5—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.021	0.021	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.0209	0.0209	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0198	0.0198	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.0194	0.0194	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0183	0.0183	CbGpPWpGaD
Vapreotide—SSTR5—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0174	0.0174	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0172	0.0172	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.0165	0.0165	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—AGTR2—dilated cardiomyopathy	0.0164	0.0164	CbGpPWpGaD
Vapreotide—SSTR2—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0161	0.0161	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—CXCR3—dilated cardiomyopathy	0.0153	0.0153	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.0129	0.0129	CbGpPWpGaD
Vapreotide—TACR1—Peptide GPCRs—AGTR1—dilated cardiomyopathy	0.0126	0.0126	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—CXCL2—dilated cardiomyopathy	0.0113	0.0113	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.0106	0.0106	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.0106	0.0106	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00989	0.00989	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00982	0.00982	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00982	0.00982	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00913	0.00913	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00898	0.00898	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00898	0.00898	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00855	0.00855	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—GJA1—dilated cardiomyopathy	0.00841	0.00841	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00835	0.00835	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00833	0.00833	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00828	0.00828	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00828	0.00828	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00818	0.00818	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00775	0.00775	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—AGTR2—dilated cardiomyopathy	0.00773	0.00773	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCL2—dilated cardiomyopathy	0.00773	0.00773	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.0077	0.0077	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00769	0.00769	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00755	0.00755	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.0075	0.0075	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00741	0.00741	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—CXCR3—dilated cardiomyopathy	0.00719	0.00719	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00715	0.00715	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00714	0.00714	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00714	0.00714	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00692	0.00692	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00673	0.00673	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00664	0.00664	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00659	0.00659	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00659	0.00659	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00643	0.00643	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—RAC1—dilated cardiomyopathy	0.00641	0.00641	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00641	0.00641	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00612	0.00612	CbGpPWpGaD
Vapreotide—SSTR5—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00608	0.00608	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00602	0.00602	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—AGTR1—dilated cardiomyopathy	0.00595	0.00595	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00593	0.00593	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00591	0.00591	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00583	0.00583	CbGpPWpGaD
Vapreotide—SSTR5—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00576	0.00576	CbGpPWpGaD
Vapreotide—SSTR2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00561	0.00561	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00549	0.00549	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00544	0.00544	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00544	0.00544	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00539	0.00539	CbGpPWpGaD
Vapreotide—SSTR2—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00531	0.00531	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00521	0.00521	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00519	0.00519	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00519	0.00519	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00507	0.00507	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00505	0.00505	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00502	0.00502	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00502	0.00502	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00489	0.00489	CbGpPWpGaD
Vapreotide—SSTR5—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00486	0.00486	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00482	0.00482	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00481	0.00481	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00467	0.00467	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00466	0.00466	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00452	0.00452	CbGpPWpGaD
Vapreotide—SSTR2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00448	0.00448	CbGpPWpGaD
Vapreotide—TACR1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00424	0.00424	CbGpPWpGaD
Vapreotide—TACR1—Peptide ligand-binding receptors—AGT—dilated cardiomyopathy	0.00418	0.00418	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00418	0.00418	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00399	0.00399	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00397	0.00397	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00395	0.00395	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00395	0.00395	CbGpPWpGaD
Vapreotide—SSTR5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00386	0.00386	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00386	0.00386	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00379	0.00379	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00378	0.00378	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00367	0.00367	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00366	0.00366	CbGpPWpGaD
Vapreotide—SSTR2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00356	0.00356	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00356	0.00356	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00307	0.00307	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00307	0.00307	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00304	0.00304	CbGpPWpGaD
Vapreotide—SSTR5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00294	0.00294	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—EGFR—dilated cardiomyopathy	0.00291	0.00291	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00288	0.00288	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00286	0.00286	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00283	0.00283	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00283	0.00283	CbGpPWpGaD
Vapreotide—SSTR2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00282	0.00282	CbGpPWpGaD
Vapreotide—TACR1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00281	0.00281	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00279	0.00279	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00279	0.00279	CbGpPWpGaD
Vapreotide—TACR1—Spinal Cord Injury—TNF—dilated cardiomyopathy	0.00278	0.00278	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00277	0.00277	CbGpPWpGaD
Vapreotide—SSTR2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00271	0.00271	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00264	0.00264	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00263	0.00263	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00259	0.00259	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00257	0.00257	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00257	0.00257	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00255	0.00255	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00251	0.00251	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00239	0.00239	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00236	0.00236	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00232	0.00232	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00224	0.00224	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00223	0.00223	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00223	0.00223	CbGpPWpGaD
Vapreotide—TACR1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00222	0.00222	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00218	0.00218	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00214	0.00214	CbGpPWpGaD
Vapreotide—TACR1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00214	0.00214	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00207	0.00207	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00207	0.00207	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00203	0.00203	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00203	0.00203	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00203	0.00203	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00201	0.00201	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00198	0.00198	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00188	0.00188	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00188	0.00188	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00186	0.00186	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00182	0.00182	CbGpPWpGaD
Vapreotide—TACR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.0018	0.0018	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00174	0.00174	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00172	0.00172	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00171	0.00171	CbGpPWpGaD
Vapreotide—SSTR5—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00166	0.00166	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00165	0.00165	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00165	0.00165	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00163	0.00163	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00161	0.00161	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00158	0.00158	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00156	0.00156	CbGpPWpGaD
Vapreotide—SSTR2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00153	0.00153	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00153	0.00153	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00152	0.00152	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00152	0.00152	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00151	0.00151	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00148	0.00148	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00148	0.00148	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00146	0.00146	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00141	0.00141	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.00139	0.00139	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00137	0.00137	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00135	0.00135	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00127	0.00127	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00126	0.00126	CbGpPWpGaD
Vapreotide—TACR1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00121	0.00121	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.0012	0.0012	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.0012	0.0012	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.0012	0.0012	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.00117	0.00117	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00115	0.00115	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00111	0.00111	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00111	0.00111	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.0011	0.0011	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00108	0.00108	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.00105	0.00105	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00103	0.00103	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000967	0.000967	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000953	0.000953	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000933	0.000933	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000921	0.000921	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—AGT—dilated cardiomyopathy	0.000892	0.000892	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000873	0.000873	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000861	0.000861	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000823	0.000823	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000761	0.000761	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000751	0.000751	CbGpPWpGaD
Vapreotide—SSTR5—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000718	0.000718	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000678	0.000678	CbGpPWpGaD
Vapreotide—SSTR2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000663	0.000663	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000648	0.000648	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000619	0.000619	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000571	0.000571	CbGpPWpGaD
Vapreotide—TACR1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000522	0.000522	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.00045	0.00045	CbGpPWpGaD
Vapreotide—SSTR5—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000424	0.000424	CbGpPWpGaD
Vapreotide—SSTR2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000392	0.000392	CbGpPWpGaD
Vapreotide—TACR1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000308	0.000308	CbGpPWpGaD
